» Articles » PMID: 32565533

Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3

Abstract

In both monoclonal gammopathy of uncertain significance (MGUS) and multiple myeloma (MM) patients, immune functions are variably impaired, and there is a high risk of bacterial infections. Neutrophils are the most abundant circulating leukocytes and constitute the first line of host defense. Since little is known about the contribution of autophagy in the neutrophil function of MGUS and MM patients, we investigated the basal autophagy flux in freshly sorted neutrophils of patients and tested the plastic response of healthy neutrophils to soluble factors of MM. In freshly sorted high-density neutrophils obtained from patients with MGUS and MM or healthy subjects, we found a progressive autophagy trigger associated with soluble factors circulating in both peripheral blood and bone marrow, associated with increased IFNγ and pSTAT3S727. In normal high-density neutrophils, the formation of acidic vesicular organelles, a morphological characteristic of autophagy, could be induced after exposure for three hours with myeloma conditioned media or MM sera, an effect associated with increased phosphorylation of STAT3-pS727 and reverted by treatment with pan-JAK2 inhibitor ruxolitinib. Taken together, our data suggest that soluble factors in MM can trigger contemporary JAK2 signaling and autophagy in neutrophils, targetable with ruxolitinib.

Citing Articles

Autophagy-related mechanisms for treatment of multiple myeloma.

Kozalak G, Kosar A Cancer Drug Resist. 2024; 6:838-857.

PMID: 38239705 PMC: 10792488. DOI: 10.20517/cdr.2023.108.


Allogeneic Anti-BCMA CAR T Cells Are Superior to Multiple Myeloma-derived CAR T Cells in Preclinical Studies and May Be Combined with Gamma Secretase Inhibitors.

Metelo A, Jozwik A, Luong L, Dominey-Foy D, Graham C, Attwood C Cancer Res Commun. 2023; 2(3):158-171.

PMID: 36874402 PMC: 9980918. DOI: 10.1158/2767-9764.CRC-21-0157.


Distinct phenotype of neutrophil, monocyte, and eosinophil populations indicates altered myelopoiesis in a subset of patients with multiple myeloma.

Ong K, Davis M, Purnell K, Cutshall H, Pal H, Connelly A Front Oncol. 2023; 12:1074779.

PMID: 36733370 PMC: 9888259. DOI: 10.3389/fonc.2022.1074779.


Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again.

Plano F, Corsale A, Gigliotta E, Camarda G, Vullo C, Di Simone M Hematol Rep. 2023; 15(1):23-49.

PMID: 36648882 PMC: 9844382. DOI: 10.3390/hematolrep15010004.


Contribution of the Tumor Microenvironment to Metabolic Changes Triggering Resistance of Multiple Myeloma to Proteasome Inhibitors.

Schwestermann J, Besse A, Driessen C, Besse L Front Oncol. 2022; 12:899272.

PMID: 35692781 PMC: 9178120. DOI: 10.3389/fonc.2022.899272.


References
1.
Romano A, Conticello C, Cavalli M, Vetro C, La Fauci A, Parrinello N . Immunological dysregulation in multiple myeloma microenvironment. Biomed Res Int. 2014; 2014:198539. PMC: 4071780. DOI: 10.1155/2014/198539. View

2.
Huo X, Li H, Li Z, Yan C, Agrawal I, Mathavan S . Transcriptomic profiles of tumor-associated neutrophils reveal prominent roles in enhancing angiogenesis in liver tumorigenesis in zebrafish. Sci Rep. 2019; 9(1):1509. PMC: 6365535. DOI: 10.1038/s41598-018-36605-8. View

3.
Romano A, Parrinello N, Vetro C, Chiarenza A, Cerchione C, Ippolito M . Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy. Ann Hematol. 2018; 97(6):1009-1018. DOI: 10.1007/s00277-018-3276-y. View

4.
Gomez J, Yamada M, Martin J, Dang H, Brickey W, Bergmeier W . Mechanisms of interferon-γ production by neutrophils and its function during Streptococcus pneumoniae pneumonia. Am J Respir Cell Mol Biol. 2014; 52(3):349-64. PMC: 4370257. DOI: 10.1165/rcmb.2013-0316OC. View

5.
Desantis V, Saltarella I, Lamanuzzi A, Mariggio M, Racanelli V, Vacca A . Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma. Transl Oncol. 2018; 11(6):1350-1357. PMC: 6132177. DOI: 10.1016/j.tranon.2018.08.014. View